CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Apr. 01, 2012
Net Cash Provided by (Used in) Operating Activities	$ (108,489)	$ (73,616)
Cash flows from investing activities of continuing operations:
Capital expenditures	(22,261)	(24,680)
Origination of finance receivables	(622,373)	(645,247)
Collections on finance receivables	665,520	681,904
Sales and redemptions of marketable securities	0	20,042
Payments for (Proceeds from) Other Investing Activities	6,656	0
Net cash (used by) provided by investing activities of continuing operations	27,542	32,019
Cash flows from financing activities of continuing operations:
Proceeds from issuance of medium-term notes	0	397,377
Repayments of securitization debt	(178,923)	(333,026)
Net (decrease) increase in credit facilities and unsecured commercial paper	392,564	(224,508)
Net borrowings of asset-backed commercial paper	(17,063)	0
Net change in restricted cash	(9,017)	(17,340)
Dividends	(47,308)	(35,943)
Purchase of common stock for treasury	(126,411)	(20,745)
Excess tax benefits from share-based payments	14,468	7,962
Issuance of common stock under employee stock option plans	13,887	16,281
Net cash (used by) provided by financing activities of continuing operations	42,197	(209,942)
Effect of exchange rate changes on cash and cash equivalents of continuing operations	(10,629)	926
Net decrease in cash and cash equivalents	(49,379)	(250,613)
Cash and cash equivalents:
Cash and cash equivalents-beginning of period	1,068,138	1,526,950
Net decrease in cash and cash equivalents	(49,379)	(250,613)
Cash and cash equivalents-end of period	$ 1,018,759	$ 1,276,337